v3.26.3
Business Segment Information - Schedule of Business Segment Information (Details) - USD ($)
$ in Millions
3 Months Ended 9 Months Ended
Sep. 26, 2026
Sep. 27, 2025
Sep. 26, 2026
Sep. 27, 2025
Dec. 31, 2025
Segment Reporting [Line Items]          
Total revenues $ 12,137 $ 11,122 $ 35,136 $ 32,341  
Selling, general and administrative expenses 2,321 2,162 6,835 6,380  
Research and development expenses 348 346 1,048 1,041  
Segment income 2,263 1,941 6,213 5,491  
Restructuring and other costs (199) (135) (346) (316)  
Amortization of acquisition-related intangible assets     (1,433) (1,294)  
Interest income 252 234 693 735  
Interest expense (417) (347) (1,172) (1,054)  
Other income/(expense) (10) (2) 13 (18)  
Consolidated income before income taxes 2,088 1,826 5,746 5,155  
Segment assets 114,233 103,020 114,233 103,020 $ 110,343
Purchases of property, plant and equipment 437 404 1,263 1,060  
Depreciation of property, plant and equipment 307 227 945 758  
Life Sciences Solutions          
Segment Reporting [Line Items]          
Total revenues 2,279 2,194 6,853 6,263  
Analytical Instruments          
Segment Reporting [Line Items]          
Total revenues 1,948 1,847 5,414 5,193  
Specialty Diagnostics          
Segment Reporting [Line Items]          
Total revenues 1,090 1,154 3,402 3,402  
Laboratory Products and Biopharma Services          
Segment Reporting [Line Items]          
Total revenues 6,820 5,927 19,467 17,483  
Segment Reconciling Items          
Segment Reporting [Line Items]          
Total revenues 546 503 1,635 1,487  
Cost of revenues adjustments (9) (10) (51) (31)  
Selling, general and administrative expenses adjustments 20 (66) (59) (99)  
Restructuring and other costs (199) (135) (346) (316)  
Amortization of acquisition-related intangible assets (519) (435) (1,433) (1,294)  
Interest income 252 234 693 735  
Interest expense (417) (347) (1,172) (1,054)  
Other income/(expense) (10) (2) 13 (18)  
Segment assets 98,834 88,209 98,834 88,209  
Purchases of property, plant and equipment 35 23 152 85  
Depreciation of property, plant and equipment 0 0 0 0  
Segment Reconciling Items | Life Sciences Solutions          
Segment Reporting [Line Items]          
Total revenues 440 394 1,317 1,165  
Segment Reconciling Items | Analytical Instruments          
Segment Reporting [Line Items]          
Total revenues 54 46 150 145  
Segment Reconciling Items | Specialty Diagnostics          
Segment Reporting [Line Items]          
Total revenues 9 20 43 54  
Segment Reconciling Items | Laboratory Products and Biopharma Services          
Segment Reporting [Line Items]          
Total revenues 43 43 125 122  
Operating Segments          
Segment Reporting [Line Items]          
Total revenues 12,683 11,626 36,771 33,828  
Segment income 2,968 2,587 8,102 7,231  
Operating Segments | Life Sciences Solutions          
Segment Reporting [Line Items]          
Total revenues 2,719 2,588 8,170 7,428  
Cost of revenues 1,013 961 3,097 2,741  
Selling, general and administrative expenses 481 471 1,477 1,405  
Research and development expenses 133 134 404 408  
Other segment items 70 54 175 152  
Segment income 1,022 968 3,017 2,722  
Restructuring and other costs (2)   (25)    
Segment assets 3,597 3,552 3,597 3,552  
Purchases of property, plant and equipment 85 32 164 101  
Depreciation of property, plant and equipment 70 62 209 177  
Operating Segments | Analytical Instruments          
Segment Reporting [Line Items]          
Total revenues 2,002 1,893 5,564 5,339  
Cost of revenues 953 974 2,754 2,711  
Selling, general and administrative expenses 323 306 951 937  
Research and development expenses 138 144 416 426  
Other segment items 51 41 127 112  
Segment income 538 429 1,317 1,153  
Restructuring and other costs (1)   (22)    
Segment assets 3,259 3,189 3,259 3,189  
Purchases of property, plant and equipment 25 18 77 75  
Depreciation of property, plant and equipment 29 26 82 76  
Operating Segments | Specialty Diagnostics          
Segment Reporting [Line Items]          
Total revenues 1,098 1,174 3,445 3,456  
Cost of revenues 587 682 1,942 2,001  
Selling, general and administrative expenses 160 175 514 529  
Research and development expenses 46 42 135 134  
Other segment items (35) (46) (133) (139)  
Segment income 341 321 987 932  
Restructuring and other costs 60   57    
Segment assets 1,129 1,307 1,129 1,307  
Purchases of property, plant and equipment 21 34 80 92  
Depreciation of property, plant and equipment 18 23 63 68  
Operating Segments | Laboratory Products and Biopharma Services          
Segment Reporting [Line Items]          
Total revenues 6,863 5,970 19,592 17,605  
Cost of revenues 5,180 4,608 15,086 13,685  
Selling, general and administrative expenses 661 577 1,935 1,760  
Research and development expenses 20 14 62 41  
Other segment items (65) (97) (273) (306)  
Segment income 1,067 868 2,781 2,425  
Restructuring and other costs (256)   (350)    
Segment assets 7,414 6,763 7,414 6,763  
Purchases of property, plant and equipment 272 297 790 707  
Depreciation of property, plant and equipment 191 115 593 439  
Elimination of intersegment revenues          
Segment Reporting [Line Items]          
Total revenues $ (546) $ (503) $ (1,635) $ (1,487)